Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,767.60
(
-1.51%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
109.10
(
2.36%
)
Bitcoin
70,827.52
(
-0.58%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: tony111 post# 76468

Thursday, 04/23/2009 2:54:27 PM

Thursday, April 23, 2009 2:54:27 PM

Post# of 257257

ANDS: combine [ANA598] with Rib you are going to have more patients dropping out from rash. The management was dumb not to raise money when they had a chance.

Agreed. ANDS may try to fall back on the lowest dose (200mg BID), but this approach is apt to end up failing the way IDIX’s NM283 did in 2007.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now